drugset / Trial / NCT05556083

Sildenafil Added Effect in Dapoxetine Non-responding Mono-symptomatic Premature Ejaculation (PE)

NCT05556083

Phase 2 Unknown 200 enrolled Al-Azhar University
RandomizedParallel-groupSingle-blindTreatment

Summary

Study Design: Single Blind Placebo Controlled Randomized Trial, aiming to assess the efficacy and safety of adding sildinafile 50 mg to dapoxitine 30 mg in dapoxitine non responding premature ejaculation.

Timeline

Start
2022-10-01
Primary completion
2023-09-29
Completion
2023-11-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Sildenafil Unknown 50 mg Oral
Comparator Dapoxetine Small molecule 30 mg Oral

Indications